Comparison of major adverse event rates after elective endovascular aneurysm repair in New England using a novel measure of complication severity Vincent J. Noori, MD, Christopher T. Healey, MD, Jens Eldrup-Jorgensen, MD, Elizabeth Blazick, MD, Robert E. Hawkins, MD, Paul H.S. Bloch, MD, Brian W. Nolan, MD, MS Journal of Vascular Surgery Volume 70, Issue 1, Pages 74-79 (July 2019) DOI: 10.1016/j.jvs.2018.10.055 Copyright © 2018 Terms and Conditions
Journal of Vascular Surgery 2019 70, 74-79DOI: (10. 1016/j. jvs. 2018 Copyright © 2018 Terms and Conditions
Fig 1 Observed major adverse event (MAE) rates. EVAR, Endovascular aneurysm repair. Journal of Vascular Surgery 2019 70, 74-79DOI: (10.1016/j.jvs.2018.10.055) Copyright © 2018 Terms and Conditions
Fig 2 Predicted major adverse event (MAE) rates. EVAR, Endovascular aneurysm repair. Journal of Vascular Surgery 2019 70, 74-79DOI: (10.1016/j.jvs.2018.10.055) Copyright © 2018 Terms and Conditions
Fig 3 This figure depicts major adverse event (MAE) rates vs complication severity index (CSI) on a normalized (NL) scale (ie, divided by the lowest equivalent rate, either MAE rate or CSI). Overall inverse relation between observed MAE rates and CSI. Journal of Vascular Surgery 2019 70, 74-79DOI: (10.1016/j.jvs.2018.10.055) Copyright © 2018 Terms and Conditions